News & Updates
Filter by Specialty:

Testosterone recovery after ADT tied to improved OS in prostate cancer
16 Apr 2025
byStephen Padilla
Testosterone recovery to a normal level appears predictive of improved overall survival (OS) among men with intermediate-risk prostate cancer who underwent androgen-deprivation therapy (ADT) and radiation therapy (RT), suggests a study.
Testosterone recovery after ADT tied to improved OS in prostate cancer
16 Apr 2025
Does CKD reduce tirzepatide benefits on HFpEF patients with obesity?
15 Apr 2025
byStephen Padilla
Long-term treatment with tirzepatide results in improved renal function in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, regardless of the absence or presence of chronic kidney disease (CKD), according to a post hoc analysis of the SUMMIT trial presented at ACC.25.